Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Growth in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 61,662 shares, an increase of 274.3% from the June 30th total of 16,476 shares. Based on an average trading volume of 256,414 shares, the days-to-cover ratio is currently 0.2 days. Approximately 12.1% of the shares of the stock are short sold.

Autonomix Medical Trading Down 4.5%

Shares of AMIX traded down $0.13 during trading hours on Monday, hitting $2.79. 291,570 shares of the stock traded hands, compared to its average volume of 128,541. Autonomix Medical has a 1-year low of $2.65 and a 1-year high of $32.55. The firm has a market capitalization of $1.51 million, a PE ratio of -0.04 and a beta of -1.32. The business has a fifty day moving average of $6.95 and a 200-day moving average of $8.00.

Analyst Ratings Changes

AMIX has been the subject of a number of research analyst reports. Weiss Ratings downgraded shares of Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research note on Friday, July 10th. Zacks Research raised shares of Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.